SNT
Click for more information
3.45% 3.0¢ syntara limited

re: re fda orpahn drug staus for cf LombardWilson's reckon $2.33...

  1. Zinc
    2,243 Posts.
    lightbulb Created with Sketch. 2
    clock Created with Sketch.
    20/07/05
    11:29
    Post #: 992272
    re: re fda orpahn drug staus for cf Lombard

    Wilson's reckon $2.33 but I'd say Whetu would probably be looking at $3.50 plus a longneck of Waikato for each share.

    Good announcement today, anticipated by the market but confirmation of the business plan being on track

    I'm looking to top up if the price falls back a little further

    Cheers
    Zinc
    PXS Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MGT Magnetite Mines set to progress DFS for Razorback through deal with JFE Shoji
right-arrow Created with Sketch.
ENR Encounter Resources flags latest niobium hits in fresh assay data
right-arrow Created with Sketch.
HCH Hot Chili sets up water company as drought racks Chile–but must also build communities a desal plant
right-arrow Created with Sketch.
NEWS Good debt vs bad debt for the property in your investment portfolio
right-arrow Created with Sketch.
CXO Core Lithium narrowly beats guidance on FY24 spodumene production but 1Y returns still shattered
right-arrow Created with Sketch.
PMT High-grade lithium zone extended at Patriot's Corvette project, drilling grades at 5%
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.0¢ 		Change
0.001(3.45%) 		Mkt cap ! $35.82M
Open High Low Value Volume
2.9¢ 3.0¢ 2.8¢ $49.35K 1.726M

Buyers (Bids)

No. Vol. Price($)
1 100000 2.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.0¢ 709077 2
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.